Analyst firms · Citigroup · MCHP
Citigroup MCHP price target and rating history
Microchip Technology Incorporated (MCHP) · Technology
Citigroup rates Microchip Technology Incorporated (MCHP) Buy with a $55 price target, as of its latest action on May 9, 2025. It has published 3 rating actions on MCHP since February 2022, including 1 upgrade and 0 downgrades. Across 6 firms with a MCHP price target in the last 12 months, the median target is $87.50.
- Current rating
- Buy
- Price target
- $55
- Median target, all firms
- $87.50
- Actions on MCHP
- 3
Citigroup price target on MCHP
Every Citigroup rating on MCHP
- May 9, 2025
- Nov 8, 2023
- Feb 4, 2022
How other firms rate MCHP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $95 | Aug 21, 2026 |
| Barclays | Equal Weight | $80 | Feb 12, 2026 |
| BofA Securities | Buy | $95 | Jan 28, 2026 |
| BNP Paribas Exane | Outperform | $90 | Jan 22, 2026 |
| Cantor Fitzgerald | Overweight | $85 | Dec 16, 2025 |
| Needham | Buy | $75 | Dec 4, 2025 |
Questions about Citigroup and MCHP
- What is Citigroup's price target for MCHP?
- Citigroup's latest stated price target for Microchip Technology Incorporated (MCHP) is $55, from its action on May 9, 2025.
- What is Citigroup's rating on MCHP?
- Citigroup rates MCHP Buy, a bullish rating, as of May 9, 2025.
- When did Citigroup last change its view on MCHP?
- On May 9, 2025, Citigroup raises its price target to $55 from $50, keeps Buy.
- How does Citigroup's MCHP target compare with other analysts?
- Across 6 firms with a MCHP price target in the last 12 months, the median target is $87.50.
More MCHP rating histories
- BofA Securities6
- TD Cowen9
- Wells Fargo4
- UBS6
- B. Riley Securities3
- Truist Securities3
- Stifel4
- Morgan Stanley5
- Mizuho4
- KeyBanc Capital Markets3
All Citigroup ratingsMCHP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.